Embl Ventures Verwaltungs Gmbh - Net Worth and Insider Trading

Embl Ventures Verwaltungs Gmbh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Embl Ventures Verwaltungs Gmbh owns 1 companies in total, including X4 Pharmaceuticals Inc (XFOR) .

Click here to see the complete history of Embl Ventures Verwaltungs Gmbh’s form 4 insider trades.

Insider Ownership Summary of Embl Ventures Verwaltungs Gmbh

Ticker	Comapny	Transaction Date	Type of Owner
XFOR	X4 Pharmaceuticals Inc	2017-11-15	10 percent owner

Embl Ventures Verwaltungs Gmbh Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Embl Ventures Verwaltungs Gmbh Ownership Network

Ownership Network List of Embl Ventures Verwaltungs Gmbh

No Data

Ownership Network Relation of Embl Ventures Verwaltungs Gmbh

Embl Ventures Verwaltungs Gmbh Owned Company Details

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Embl Ventures Verwaltungs Gmbh is the 10 percent owner of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include director & President and CEO Paula Ragan , Chief Scientific Officer Arthur Taveras , and Chief Operating Officer Mary Dibiase .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Embl Ventures Verwaltungs Gmbh made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 601,883 shares made by Paula Ragan , a net sale of 161,480 shares made by Mary Dibiase , and a net sale of 552,345 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 660,362 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 660,362 shares. During the past 18 months, 1,626,785 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,601,785 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

Embl Ventures Verwaltungs Gmbh Mailing Address

Above is the net worth, insider trading, and ownership report for Embl Ventures Verwaltungs Gmbh. You might contact Embl Ventures Verwaltungs Gmbh via mailing address: Boxbergring 107, Heidelberg 2m 69126.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.